Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
H-PAT: Amlodipine in Hereditary Pancreatitis
NCT00156403Phase 2Completed
- Sponsor
- University of Pittsburgh
- Start
- Aug 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of amlodipine in hereditary pancreatitis (HP), sponsored by University of Pittsburgh. Started Aug 2005; status: completed.
02
Drugs
amlodipine
03
Conditions
hereditary pancreatitis (HP)
Beyond the preview
Go deeper on NCT00156403.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00156403.